Head to head

Splendor X vs Duetto MT (2026)

Compare purchase costs, running costs and the evidence behind each device.

Read the comparison overview

Purchase cost: Catalog new-price ranges: Splendor X, $130k–$165k; Duetto MT, $80k–$120k. Check the source notes and request current quotes.
Practice fit: Both are listed under dual-wavelength laser. Check each model’s US regulatory status and labeled indications for your intended use.

Device A

Dual-wavelength laser

View full device profile →

Device B

Dual-wavelength laser

View full device profile →

Price comparison

Price comparison: Lumenis Splendor X vs Quanta System Duetto MT / MT Evo
Attribute	Lumenis Splendor X	Quanta System Duetto MT / MT Evo
New price range	$130k–$165kSource not documented	$80k–$120kSource not documented
Used asking range	$70k–$110kSource not documented	$30k–$60kSource not documented
Payback calculator	View ROI calculator	View ROI calculator
Next step

New price range

Lumenis Splendor X: $130k–$165kSource not documented
Quanta System Duetto MT / MT Evo: $80k–$120kSource not documented

Used asking range

Lumenis Splendor X: $70k–$110kSource not documented
Quanta System Duetto MT / MT Evo: $30k–$60kSource not documented

Payback calculator

Lumenis Splendor X: View ROI calculator
Quanta System Duetto MT / MT Evo: View ROI calculator

Next step

Lumenis Splendor X

Quanta System Duetto MT / MT Evo

Consumable economics

Consumable economics: Lumenis Splendor X vs Quanta System Duetto MT / MT Evo
Attribute	Lumenis Splendor X	Quanta System Duetto MT / MT Evo
Consumable cost / lock-in	No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.	—
Service cost	Not published	Not published

Consumable cost / lock-in

Lumenis Splendor X: No per-treatment disposable. The recurring cost is wear parts — handpiece lenses, flashlamp, protective windows, ceramic reflector, Nd:YAG and alexandrite rods, fibre window. Not published — Lumenis does not publish US wear-part pricing and the figures previously shown carried no dated source.
Quanta System Duetto MT / MT Evo: —

Service cost

Lumenis Splendor X: Not published
Quanta System Duetto MT / MT Evo: Not published

FDA clearance

FDA clearance: Lumenis Splendor X vs Quanta System Duetto MT / MT Evo
Attribute	Lumenis Splendor X	Quanta System Duetto MT / MT Evo
FDA status & indication	FDA ClearedK241407, K243445 Read FDA indication wording “The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”	FDA ClearedK192160, K223404 Read FDA indication wording “The EVO Platform is intended for use in aesthetic, cosmetic and surgical applications requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general, plastic and oral surgery as follows. 1064 & 532 nm (Q-Switched, nanosecond mode) The EVO Platform is intended for treatment of vascular lesions, pigmented lesions, and for hair, tattoo removal and the incision, excision, ablation, vaporization of soft tissue for General dermatology such as, but not limited to treatment of: 532 nm (Q-Switched, nanosecond mode) Removal of light ink (red, sky blue, green, tan, purple, and orange) tattoos Treatment of vascular lesions including, but not limited to: - port wine birthmarks - telangiectasias - spider angiomaa - Cherry angioma - Spider nevi Treatment of benign pigmented lesions including, but not limited to: - cafe-au-Iait birthmarks - Ephalides, solar lentigines - senile lentigines - Becker's nevi - freckles - common nevi - nevus spilus - Ota Nevus Treatment of seborrheic keratosis Treatment of post inflammatory hyperpigmentation Skin resurfacing procedures for the treatment of acne scars and wrinkles.”

FDA status & indication

Lumenis Splendor X: FDA ClearedK241407, K243445
Read FDA indication wording
“The Nd:YAG 1064 Laser is intended for: • Removal of unwanted hair, for stable long term or permanent hair reduction and for treatment of Pseudofolliculitis barbae (PFB). Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. The lasers are indicated on all skin types, such as Fitzpatrick I-VI, including tanned skin. • Photocoagulation and hemostasis of benign pigmented and vascular lesions such as, but not limited to, port-wine stains, hemangioma, warts, telangiectasia, rosacea, venous lake, leg veins and spider veins. • Coagulation and hemostasis of soft tissue. • Treatment of benign pigmented lesions such as, but not limited to, lentigos (age spots), solar lentigos (sunspots), cafe au lait macules, seborrheic keratosis, nevi, chloasma, verrucae, skin tags, keratosis, tattoos (significant reduction in the intensity of black and/or blue-black tattoos) and plaques. The laser is indicated for benign pigmented lesions to reduce lesion size, for patients with benign lesions that would potentially benefit from aggressive treatment, and for patients with benign lesions that have not responded to other laser treatments. • Reduction of red pigmentation in hypertrophic and keloid scars where vascularity is an integral part of the scar. • Treatment of wrinkles. • Temporary increase of clear nail in patients with onychomycosis (e.g., dermatophytes, Trichophyton rubrum and T. mentagrophytes, and/or yeast Candida Albicans, etc.). The Alexandrite 755 laser is intended for: • Temporary hair reduction. • Stable long-term or permanent hair reduction through selective targeting of melanin in hair follicles. Permanent hair reduction is defined as the long-term, stable reduction in the number of hairs regrowing when measured at 6, 9, and 12 months after the completion of a treatment regime. On all skin types, such as Fitzpatrick I – VI, including tanned skin. • Treatment of benign pigmented lesions. • Treatment of wrinkles. • Photocoagulation of dermatological benign vascular lesions (such as port-wine stains, hemangiomas, telangiectasias).”
Quanta System Duetto MT / MT Evo: FDA ClearedK192160, K223404
Read FDA indication wording
“The EVO Platform is intended for use in aesthetic, cosmetic and surgical applications requiring incision, excision, ablation, vaporization and coagulation of body soft tissues in the medical specialties of dermatology, general, plastic and oral surgery as follows. 1064 & 532 nm (Q-Switched, nanosecond mode) The EVO Platform is intended for treatment of vascular lesions, pigmented lesions, and for hair, tattoo removal and the incision, excision, ablation, vaporization of soft tissue for General dermatology such as, but not limited to treatment of: 532 nm (Q-Switched, nanosecond mode) Removal of light ink (red, sky blue, green, tan, purple, and orange) tattoos Treatment of vascular lesions including, but not limited to: - port wine birthmarks - telangiectasias - spider angiomaa - Cherry angioma - Spider nevi Treatment of benign pigmented lesions including, but not limited to: - cafe-au-Iait birthmarks - Ephalides, solar lentigines - senile lentigines - Becker's nevi - freckles - common nevi - nevus spilus - Ota Nevus Treatment of seborrheic keratosis Treatment of post inflammatory hyperpigmentation Skin resurfacing procedures for the treatment of acne scars and wrinkles.”

Which chains run each

Which chains run each: Lumenis Splendor X vs Quanta System Duetto MT / MT Evo
Attribute	Lumenis Splendor X	Quanta System Duetto MT / MT Evo
Chain adoption	0 recorded pairings	0 recorded pairings
Chains using it	—	—
Approved reviews	0	0

Chain adoption

Lumenis Splendor X: 0 recorded pairings
Quanta System Duetto MT / MT Evo: 0 recorded pairings

Chains using it

Lumenis Splendor X: —
Quanta System Duetto MT / MT Evo: —

Approved reviews

Lumenis Splendor X: 0
Quanta System Duetto MT / MT Evo: 0

Specs and platform

Specs and platform: Lumenis Splendor X vs Quanta System Duetto MT / MT Evo
Attribute	Lumenis Splendor X	Quanta System Duetto MT / MT Evo
Manufacturer	Lumenis	Quanta System
Built by (OEM)	Lumenis Be Ltd.	Quanta System S.p.A.
Category	Dual-wavelength laser	Dual-wavelength laser
Technology	755+1064nm BLEND X square spot	755+1064nm Mixed Technology pulses
Launch year	2018	2010
Status	Current	Current
Manufacturer source record	No linked source on file.	No linked source on file.

Manufacturer

Lumenis Splendor X: Lumenis
Quanta System Duetto MT / MT Evo: Quanta System

Built by (OEM)

Lumenis Splendor X: Lumenis Be Ltd.
Quanta System Duetto MT / MT Evo: Quanta System S.p.A.

Current alternatives

Current catalog models in related categories. Confirm availability and configuration with the supplier.

Cutera Excel HR

Dual-wavelength laser

New: $95k–$135k

Lutronic Clarity II

Dual-wavelength laser

New: $100k–$140k

Quanta System Thunder (MT)

Dual-wavelength laser

New: $110k–$150k

Get a free recommendation Browse by goal

Device and company names are trademarks of their respective owners. The Aesthetic Index is not affiliated with or endorsed by any manufacturer, distributor or lender named here, except as disclosed. Price figures are references, not current offers. Check each device’s source notes. Not medical, legal or regulatory advice.